By far the worst performer was IQE:IQE, which after saying the Huawei issues wouldn't have much affect, have now changed their mind and decided this is going to be a pretty bad year. The shorters rubbed their hands with glee and attacked. My new ISA holding fell 29% of my purchase price, my trading account holding fell 20% and my SIPP holding fell 16%. It knocked over £1,000 off my portfolio value on relatively small holdings.
VRS:Versarien also tanked, dropping 13% and going into the red. Why didn't I bank profits while I had a chance? This was always going to be a volatile share and a dream for traders.
TEK:Tekcapital had looked like making a recovery for my trading account, but lost nearly all last week's gains as it dropped 11% and is back to being a long way from sellable.
TND:Tandem Group was in profit, but not any longer as it fell 10% on Friday despite only 6 trades, of which there were three times as many buys as sells. Can anyone explain that? Suspecting foul play, I'm going to close my limit order as something may be afoot and I don't want to be tied to my current limit.
OPTI:Optibiotix is having another trader-induced slump and fell 5p which is 8% and accounted for £4,145 of this week's deficit. The fact that I lost over £1,100 from my other shares shows haw dreadful a week this was.
MMX:Minds + Machines was meant to be a quick win but is now turning into a very slow value trap, and fell another 6% to go 29% down. I'm still confident these will show good cash generation when the next results come out, but will the board give anything back to shareholders? Last time they bought another company instead, which isn't a bad thing, but hammered the share price as people expected this to start paying dividends by now.
TRX:Tissue Regenix was probably victim of the great Woodford sell-off and dropped 6% to go 78% down.
There was only one share that managed to hit a 5% climb this week, so Share of the Week goes to JLP:Jubilee Metals. Given the price of gold has soared this week, I expected it to be CEY:Centamin, but that only climbed 2%. Platinum isn't following gold like it used to, but if it decided to try and catch up then things would look even better for JLP.
Bugger
Oh well, heading towards biggest deficit this year and the performance has dropped well below the trend line. It's been declining steadily for the last 6 months and no sign of reversal.
Here's the ISA and share accounts performance
| Weekly Change | |||
| Cash | £23.23 | +£0 | |
| Portfolio cost | £57,827.12 | +£0 | |
| Portfolio sell value (bid price-commission) | £49,899.82 | (-17.7%) | -£2,980.01 |
| Potential profits | £3,275.29 | -£2,531.06 | |
| Yr 4 Dividends | £88.07 | +£0 | |
| Yr 4 Profit from sales | £1,606.13 | +£0 | |
| Yr 4 Average monthly cash profit | £156.07 | (3.2%) | -£3.46 |
| Total Dividends | £1,326.40 | +£0 | |
| Total Profit from sales | £20,303.25 | +£0 | |
| Average monthly cash profit | £460.05 | (9.5%) | -£2.29 |
| (Sold stocks profit + Dividends - Fees / Months) |
Over £2,500 wiped off paper profits and and additional £400 drop through deepening losses. My cunning plan to make a quick buck from IQE:IQE so I could buy back into SBTX:SkinBioTherapeutics looked sound last week. This week it looks like a catastrophe. If I'm going to trade a share I really must learn to keep the cash in the account and not put it somewhere it's at risk. If SBTX drops now, I have absolutely no way to take advantage. Really, really bad mistake.
Dire
Also dire.
Here's the SIPP after week 186
| Weekly Change | |||
| Cash | £84.80 | +£0 | |
| Portfolio cost | £41,248.68 | +£0 | |
| Portfolio sell value (bid price - commission) | £39,116.84 | (-5.2%) | -£2,143.77 |
| Potential profits | £2,606.79 | -£1,547.39 | |
| Yr 4 Dividends | £361.99 | +£0 | |
| Yr 4 Interest | £0.07 | +£0 | |
| Yr 4 Profit from sales | £732.65 | +£0 | |
| Yr 4 Average monthly cash profit | £144.89 | (4.2%) | -£5.00 |
| Total Dividends | £1,704.24 | +£0 | |
| Total Interest | £0.10 | +£0 | |
| Total Profit from sales | £11,277.57 | +£0 | |
| Average monthly cash profit | £293.74 | (8.5%) | -£1.59 |
| (Sold stocks profit + Dividends - Fees / Months) |
Potential profits down by £1,500, but then losses deepening by an additional £600 as some of the week's worst performers were in this account. Average performance is getting worryingly below target 10% but there's nothing I can do to turn it around, or at least there's nothing I'm prepared to do right now.
This account is rarely in the red, so this is a very sorry sight.
Just like the other charts. Maybe I need to stop buying the same shares in both accounts as it doesn't give much variety when so many are shared.
The trading account looks like this after week 152
| Weekly Change | |||
| Cash | £35.04 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,404.72 | (-39.5%) | -£137.50 |
| Potential profits | £0 | +£0 | |
| Year 3 Dividends | £33.57 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £19.02 | (9.8%) | -£0.40 |
| Dividends | £34.72 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.84 | (-0.4%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
One of the worst weeks ever, mainly due to big drops for IQE:IQE and TEK:Tekcapital. Rising optimism has just been crushed.
Ouch!
It's not even good that we're above the trend line because it's a devastating trend line.
I'm too miserable to write any more this week.
No comments:
Post a Comment